Search results
Showing 3451 to 3500 of 3761 results for treatment
Ivosidenib for treating relapsed or refractory IDH1-positive acute myeloid leukaemia [ID1548]
Discontinued Reference number: GID-TA10416
In development Reference number: GID-TA11277 Expected publication date: TBC
This manual explains how NICE develops and updates social care guidance. It provides advice on the technical aspects of guidance development and the methods used
Transperineal biopsy for diagnosing prostate cancer (HTG680)
Evidence-based recommendations on transperineal biopsy for diagnosing prostate cancer.
Discontinued Reference number: GID-TA10202
YOURmeds for medication support in long-term conditions (MIB289)
NICE has developed a medtech innovation briefing (MIB) on YOURmeds for medication support in long-term conditions .
committee's discussion are in evidence review K: cessation and harm-reduction treatments. Source guidance details Comes from guidance...
committee's discussion are in evidence review K: cessation and harm-reduction treatments. Source guidance details Comes from guidance...
evidence and the committee's discussion are in evidence review H: initial treatments for differentiated thyroid cancer. Source guidance...
committee made the recommendation for research, see the rationale section on treatments for moderate and severe OSAHS . Full details of...
committee made the recommendation for research, see the rationale section on treatments for moderate and severe OSAHS. Full details of...
i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department (MIB38)
NICE has developed a medtech innovation briefing (MIB) on i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department
people with dementia, their families and the NHS, and there is no effective treatment to prevent its progression.Hearing loss is...
committee's discussion are in evidence review K: cessation and harm-reduction treatments. Source guidance details Comes from guidance...
committee made the recommendation for research, see the rationale section on treatments for mild OSAHS . Full details of the evidence...
committee's discussion are in evidence review K: cessation and harm-reduction treatments. Source guidance details Comes from guidance...
discussion are in: - evidence review K: cessation and harm-reduction treatments - evidence review M: long-term health effects of...
This guideline covers changing health-damaging behaviours among people aged 16 and over using interventions such as goals and planning, feedback and monitoring, and social support. It aims to help tackle a range of behaviours including alcohol misuse, poor eating patterns, lack of physical activity, unsafe sexual behaviour and smoking.
opioids and compound analgesics) are sometimes used with disease-modifying treatments to relieve pain and stiffness when symptom control...
comorbidities, COVID-19 vaccination status,)• association of CAPA with COVID-19 treatments (for example, respiratory support for...
NICE's past research and projects
NICE has developed a Medtech Innovation Briefing (MIB) on the OSCAR 3 ultrasonic arthroplasty revision instrument for removing bone cement during prosthetic
to women at high risk of developing breast cancer and considering such treatments as chemoprevention for women at moderate risk. One...
of oral health interventions to ensure equitable access to oral health treatments and services.This data is needed for evaluation...
However, subgroups of these people may benefit particularly from this treatment.Identifying and targeting prophylactic antibiotics for...
stratified into those with and without refractory IBS and then randomised to treatments. The primary outcome should be global...
widespread pain syndrome, which is not inflammatory. These need very different treatments, so it is important to define them accurately....
be used at an early stage as a means of preventing progression to drug treatments, which are associated with a number of undesirable...
children and young people in whom the use of appropriate non-invasive treatments did not relieve difficulties associated with spasticity...
The hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability (MIB7)
NICE has developed a Medtech Innovation Briefing (MIB) on the hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability
recommendationsDiverticulosis is asymptomatic and there are no specific treatments for it. The committee therefore considered making a...
areavailable in oral preparations (perhaps more suitable for outpatient treatments) with establishedtreatments such as LMWH or...
Evidence-based recommendations on insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section. The catheter aims to help induction by causing dilation of the cervix when the cervix is unfavourable for induction. The double balloon squeezes the cervix and stimulates local prostaglandin release, which leads to cervical ripening.
Charging procedure for NICE technology appraisal and highly specialised technologies evaluations
This guideline covers indoor air quality in residential buildings. It aims to raise awareness of the importance of good air quality in people's homes and how to achieve this.
This guideline covers how to create the right conditions for mental wellbeing at work. It aims to promote a supportive and inclusive work environment, including training and support for managers and helping people who have or are at risk of poor mental health.
non-psychotic outcomes. Why this is important:- A major problem with trials of treatments for populations of children and young people...
Robot-assisted surgery for orthopaedic procedures: early value assessment (HTG743)
Early value assessment (EVA) guidance on robot-assisted surgery for orthopaedic procedures.
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence in mammography .
NICE has developed a medtech innovation briefing (MIB) on AI technologies for detecting diabetic retinopathy .
include details of patient selection such as body mass index and other treatments such as diet and lifestyle changes. They should also...
NICE announces Professor Jonathan Benger as new Chief Executive
NICE Chairman, Sharmila Nebhrajani, today announced Professor Jonathan Benger CBE as incoming chief executive, with effect from Friday 19 December 2025 taking over from Dr Samantha Roberts.
In development Reference number: GID-TA11546 Expected publication date: TBC
research, the timing of selective dorsal rhizotomy in relation to other treatments such as orthopaedic surgery, and information that...
Suture fixation of acute disruption of the distal tibiofibular syndesmosis (HTG374)
Evidence-based recommendations on suture fixation of acute disruption of the distal tibiofibular syndesmosis. This involves threading a suture through a tunnel made in the bones (tibia and fibula) and tying the ends together to fix the joint.
PLGF-based testing to help diagnose suspected preterm pre-eclampsia (HTG630)
Evidence-based recommendations on placental growth factor (PLGF)-based testing to help diagnose suspected preterm pre-eclampsia. The tests are: DELFIA Xpress PLGF 1-2-3, DELFIA Xpress sFlt-1/PLGF 1-2-3 ratio, Elecsys immunoassay sFlt-1/PLGF ratio, Triage PLGF Test.
NICE has developed a medtech innovation briefing (MIB) on Airglove air warming system for venous access .
other options for maintaining remission. Toavoid unnecessarily changing treatments for people who started taking biologics before...
In development Reference number: GID-TA11745 Expected publication date: TBC
How we collect and use your personal information, and your rights under data protection legislation.